dc.date.accessioned | 2022-01-18T19:26:50Z | |
dc.date.available | 2022-01-18T19:26:50Z | |
dc.date.created | 2022-01-18T19:26:50Z | |
dc.date.issued | 2012 | |
dc.identifier | https://hdl.handle.net/20.500.12866/10922 | |
dc.identifier | https://doi.org/10.1055/s-0031-1298459 | |
dc.description.abstract | Two new dihydrochalcones, as well as eight known compounds, piperaduncin C, 2,6-dihydroxy-4-methoxydihydrochalcone, 4,2,6-trihydroxy-4-methoxydihydrochalcone, 4-hydroxy-3,5-bis(3-methyl-2- butenyl)-benzoic acid, 3,5-bis(3-methyl-2-butenyl)-4-methoxybenzoic acid, 4-hydroxy-3-(3-methyl-2-butenoyl)-5-(3-methyl-2-butenyl)-benzoic acid, 2,2-dimethyl-8-(3-methyl-2-butenyl)-2H-1-chromene-6-carboxylic acid, and 3-(3,7-dimethyl-2,6-octadienyl)-4-methoxybenzoic acid were isolated from the leaves of Piper dennisii Trelease (Piperaceae), using a bioassay-guided fractionation to determine their antileishmanial potential. Among them, compound 10 exhibited the best antileishmanial activity (IC= 20.8 M) against axenic amastigote forms of Leishmania amazonensis, with low cytotoxicity on murine macrophages. In the intracellular macrophage-infected model, compound 10 proved to be more active (IC= 4.2 M). The chemical structures of compounds 1-10 were established based on the analysis of the spectroscopic data. | |
dc.language | eng | |
dc.publisher | Georg Thieme Verlag | |
dc.relation | Planta Medica | |
dc.relation | 1439-0221 | |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | Controlled Study | |
dc.subject | Animal Cell | |
dc.subject | Amastigote | |
dc.subject | Disease Model | |
dc.subject | Macrophage | |
dc.subject | Leishmania | |
dc.subject | Plant Extract | |
dc.subject | Amphotericin B | |
dc.subject | Drug Isolation | |
dc.subject | Molecular Structure | |
dc.subject | Plant Leaf | |
dc.subject | Cytotoxicity | |
dc.subject | Drug Structure | |
dc.subject | Murinae | |
dc.subject | Antiprotozoal Agents | |
dc.subject | IC 50 | |
dc.subject | Leishmania Amazonensis | |
dc.subject | Antileishmanial Agent | |
dc.subject | Drug Activity | |
dc.subject | Chalcone Derivative | |
dc.subject | Chalcones | |
dc.subject | Inhibitory Concentration 50 | |
dc.subject | Macrophages Peritoneal | |
dc.subject | Bioassay | |
dc.subject | Fractionation | |
dc.subject | Spectroscopy | |
dc.subject | Piperaceae | |
dc.subject | Piper | |
dc.subject | Chemical Structure | |
dc.subject | 22 Dimethyl 8 (3 Methyl 2 Butenyl) 2h 1 Chromene 6 Carboxylic Acid | |
dc.subject | 2'6' Dihydroxy 4' Methoxydihydrochalcone | |
dc.subject | 3 (3'7' Dimethyl 2'6' Octadienyl) 4 Methoxybenzoic Acid | |
dc.subject | 35 Bis(3 Methyl 2 Butenyl) 4 Methoxybenzoic Acid | |
dc.subject | 4 Hydroxy 3 (3 Methyl 2 Butenoyl) 5 (3 Methyl 2 Butenyl)Benzoic Acid | |
dc.subject | 4 Hydroxy 35 Bis(3 Methyl 2 Butenyl)Benzoic Acid | |
dc.subject | 42'6' Trihydroxy 4' Methoxydihydrochalcone | |
dc.subject | Antileishmanial Activities | |
dc.subject | Benzoic Acid Derivative | |
dc.subject | Benzoic Acids | |
dc.subject | Dihydrochalcones | |
dc.subject | Drug Evaluation Preclinical | |
dc.subject | Piper (Plant) | |
dc.subject | Piper Dennisii|Piperaduncin C | |
dc.title | Dihydrochalcones and benzoic acid derivatives from piper dennisii | |
dc.type | info:eu-repo/semantics/article | |